TY  - JOUR
T1  - SUCCESSFUL TREATMENT OF PULMONARY EMBOLISM AND ASSOCIATED UPPER EXTREMITY ARTERY THROMBOSIS USING INTRAVENOUS ALTEPLASE: A CASE REPORT
AU  - Karaman, Kivanc
AU  - Celik, Cihangir
AU  - Oskay, Alten
AU  - Armağan, Hamit Hakan
AU  - Tomruk, Onder
PY  - 2019
DA  - April
DO  - 10.33706/jemcr.551134
JF  - Journal of Emergency Medicine Case Reports
PB  - Acil Tıp Uzmanları Derneği
WT  - DergiPark
SN  - 2149-9934
SP  - 39
EP  - 42
VL  - 10
IS  - 2
LA  - en
AB  - Introduction: Although thrombolyticadministration is inevitable in the management of massive pulmonary embolism,contradictions exist in the treatment of sub-massive pulmonary embolism. Thereare drawbacks to thrombolytic treatment due to potential serious side effectssuch as cranial hemorrhage. Case Report: An 84-year-old female patient wasadmitted to the emergency service because of pain and lack of a pulse in herright arm and %61 oxygen saturation without any respiratory system complaints.A computerized tomography showed pulmonary embolism close to totality in thebilateral main pulmonary arteries and peripheral embolism in the right brachialartery. We considered a sub-massive pulmonary embolism in this patient with nohypotension despite bilateral pulmonary artery embolism, good generalcondition, but a dilated right ventriculi in transthoracic echocardiography.Since the PESI score was 115, it was decided that the patient was in thehigh-risk group. After administration of 100 mg Alteplase as thrombolytictherapy, her oxygen saturation increased to 95% in the room air and hercomplaint of right arm completely regressed. Furthermore, none of the possiblecomplications from thrombolytic therapy, such as fatal bleeding, were observedin our patient. Conclusion: In this article, it is emphasizedthat thrombolytic therapy is an appropriate choice for patients withsub-massive pulmonary embolism and acute arterial embolism.
KW  - Emergency service
KW  - Peripheral arterial embolism
KW  - Pulmonary embolism
CR  - 1. Teleb M, Porres-Aguilar M, Anaya-Ayala JE, Rodriguez-Castro C, Porres-Muñoz M, Mukherjee D. Potential role of systemic thrombolysis in acute submassive intermediate risk pulmonary embolism: review and future perspective. Ther Adv Cardiovasc Dis 2016; 10(2): 103–10.
CR  - 2. Long B, Koyfman A. Current Controversies In Thrombolytic Use In Acute Pulmonary Embolism. The Journal of Emergency Medicine 2016; 51(1): 37–44.
CR  - 3. Baile´n MR, Cuadra JA, Aguayo De Hoyos E. Thrombolysis During Cardiopulmonary Resuscitation In Fulminant Pulmonary Embolism: A Review. Crit Care Med 2001; 29: 2211–9.
CR  - 4. Konstantinides S, Geibel A, Heusel G, Heinrich F, Kasper W. Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolism. N Engl J Med 2002; 347: 1143–50.
CR  - 5. Sharifi M, Bay C, Skrocki L, Rahimi F, Mehdipour M. Moderate pulmonary embolism treated with thrombolysis (from the MOPETT trial). Am J Cardiol 2013; 111: 273–7.
CR  - 6. Gao G, Yang P, Liu M, Din M, Liu G, Tong Y, et al. Thrombolysis for acute intermediaterisk pulmonary embolism: a meta-analysis. Thromb Res 2015; 136: 932–7.
CR  - 7. Kearon C, Akl EA, Ornelas J, Blaivas A, Jimenez D, Bounameaux H, et al. Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report. Chest 2016; 149: 315-52.
CR  - 8. Van der Hulle T,  Kooiman J,  Den Exter PL,  Dekkers OM,  Klok FA,  Huisman MV. Effectiveness and safety of novel oral anticoagulants as compared with vitamin K antagonists in the treatment of acute symptomatic venous thromboembolism: a systematic review and meta-analysis. J Thromb Haemost 2014; 12(3): 320-8.
CR  - 9. Christine GK, Gregory JF, William FP, Phil SW, Christopher WB, Veronica A, et al. Association between rivaroxaban use and length of hospital stay, treatment costs and early outcomes in patients with pulmonary embolism:a systematic review of real-world studies. Current Medical Research and Opinion 2017; 33(9): 1697-703.
CR  - 10. Işık GC, Çorbacıoğlu SK, Cevik Y. Watershed Infarct due to Massive Pulmonary Embolism: A Rare Diagnosis at the Emergency Department. JEMCR 2016; 7: 34-6.
CR  - 11. Zhang HL, Liu ZH, Luo Q, Wang Y, Zhao ZH, Xiong CM. Paradoxical embolism: Experiences from a single center. Chronic Diseases and Translational Medicine 2017; 3: 123-8.
UR  - https://doi.org/10.33706/jemcr.551134
L1  - https://dergipark.org.tr/en/download/article-file/690964
ER  -